Guardian Pharmacy Service...

NYSE: GRDN · Real-Time Price · USD
22.22
-0.36 (-1.59%)
At close: May 23, 2025, 3:59 PM
22.00
-0.99%
After-hours: May 23, 2025, 05:25 PM EDT

Guardian Pharmacy Services Statistics

Share Statistics

Guardian Pharmacy Services has 63.29M shares outstanding. The number of shares has increased by null% in one year.

Shares Outstanding 63.29M
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Institutions (%) n/a
Shares Floating n/a
Failed to Deliver (FTD) Shares 1,611
FTD / Avg. Volume 1.66%

Short Selling Information

The latest short interest is 992.24K, so 1.57% of the outstanding shares have been sold short.

Short Interest 992.24K
Short % of Shares Out 1.57%
Short % of Float 7.88%
Short Ratio (days to cover) 10.93

Valuation Ratios

The PE ratio is -14.39 and the forward PE ratio is 21.51. Guardian Pharmacy Services's PEG ratio is 0.03.

PE Ratio -14.39
Forward PE 21.51
PS Ratio 1.02
Forward PS 0.9
PB Ratio 8.81
P/FCF Ratio 30.2
PEG Ratio 0.03
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Guardian Pharmacy Services.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.05, with a Debt / Equity ratio of 0.21.

Current Ratio 1.05
Quick Ratio 0.77
Debt / Equity 0.21
Debt / EBITDA -0.69
Debt / FCF 0.72
Interest Coverage -19.19

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $361,296.76
Profits Per Employee $-25,672.65
Employee Count 3,400
Asset Turnover 3.83
Inventory Turnover 24.27

Taxes

Income Tax 4.56M
Effective Tax Rate -6.85%

Stock Price Statistics

The stock price has increased by null% in the last 52 weeks. The beta is 3.53, so Guardian Pharmacy Services's price volatility has been higher than the market average.

Beta 3.53
52-Week Price Change n/a
50-Day Moving Average 23.05
200-Day Moving Average n/a
Relative Strength Index (RSI) 39.53
Average Volume (20 Days) 96,957

Income Statement

In the last 12 months, Guardian Pharmacy Services had revenue of 1.23B and earned -87.29M in profits. Earnings per share was -1.41.

Revenue 1.23B
Gross Profit 244.37M
Operating Income -62.92M
Net Income -87.29M
EBITDA -43.43M
EBIT -63.2M
Earnings Per Share (EPS) -1.41
Full Income Statement

Balance Sheet

The company has 4.66M in cash and 30.13M in debt, giving a net cash position of -25.47M.

Cash & Cash Equivalents 4.66M
Total Debt 30.13M
Net Cash -25.47M
Retained Earnings 17.12M
Total Assets 334M
Working Capital 20.75M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 57.96M and capital expenditures -16.37M, giving a free cash flow of 41.59M.

Operating Cash Flow 57.96M
Capital Expenditures -16.37M
Free Cash Flow 41.59M
FCF Per Share 0.67
Full Cash Flow Statement

Margins

Gross margin is 19.89%, with operating and profit margins of -5.12% and -7.11%.

Gross Margin 19.89%
Operating Margin -5.12%
Pretax Margin -5.41%
Profit Margin -7.11%
EBITDA Margin -3.54%
EBIT Margin -5.12%
FCF Margin 3.39%

Dividends & Yields

GRDN does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for GRDN is $24.5, which is 10.3% higher than the current price. The consensus rating is "Strong Buy".

Price Target $24.5
Price Target Difference 10.3%
Analyst Consensus Strong Buy
Analyst Count 2
Stock Forecasts

Scores

Altman Z-Score 8.86
Piotroski F-Score 6